FLT3 and acute myeloid leukemia: This and our previous studies show that the idea of an AML-subtype-specific GRN that maintains AML cells is not only true for groups affected by mutations of gene regulatory molecules themselves but also for those with signaling mutations who generate chronic growth signals, such as the FLT3-ITD.